International Bladder Cancer Network

Update - March 2002


First Announcement of a 3rd IBCN meeting

“The goals of such a meeting are many, and so success will be defined differently by all. However, I think that progress towards actual international collaboration is essential. In my view, this meeting will succeed if it is a working meeting to further ongoing collaborations. I hope that we can bring together the right set of people who are interested in pooling our resources and expertise towards this goal.”
                                                                                                                                                                           Fred  Waldman, San Francisco
 
 
Bernd J. Schmitz-Dräger
Department of Urology
EuromedClinic
Europa-Allee 1
D-90763 Fürth, Germany
bsd@euromed.de
bladder bank
International Bladder Cancer Network

Tentative Program 3rd Meeting of the IBCN,
Trento/Italy, October 23-24, 2002


Wednesday, 23.10.2002
Time          Topic                                                                     Presentation

09:00          Welcome                                                            Luciani, Bassi
09:10          The IBCN – Past, presence, future                    Grossman

Session I: Achievements
Chair: Fradet, Algaba

09:30          The ISBC trial – final results                               Schmitz-Dräger
10:00          Technical aspects of marker research               N.N.
10:30           I – Assessment:
                    Lessons from the p53 standardization trial         McShane
11:00           II - Technical issues                                            Goebell
11:30           III – GCP in marker research:
                    The variability index                                           Groshen
12:00           Epidemiology                                                     Malats

12:30-13:30 Buffet lunch

Session II: Ongoing Activities
Chair: Cote, Busch

13:30           Introductional overview:
                    The EORTC experience with clinical networks   Sylvester
14:00           International bladder cancer bank                       Goebell
14:15           Bladder cancer arrays                                         Sauter
14:30           Bladder cancer arrays - International                  Waldman
14:45           The Mund - Study                                               Björnson

15:00-15:30 Coffee break

Session III: IBCN – Network within networks: putative partners
Chair: Grossman, Bassi

15:30           EORTC                                                              Busch
15:45           EAU                                                                                     N.N.
16:00           ESUR                                                                 Bassi
16:15           NCI                                                                     Gomez
16:30           EU                                                                      N.N.
16:45           Defining the goals                                              Chairmen working groups
17:30           First meeting of working groups,
                    Introduction by the speakers                              (see Thursday program)

19:30           Dinner
 

Thursday, 24.10.2002

Time          Topic                                                                     Presentation

08:30         Working groups

                   I.  Technical innovations                                      Busch, Cordon-Cardo,
                            (models, arrays etc.)                                                  Waldman

                   II.  Statistical needs & GCP                                  Groshen, Montironi,
                                                                                                Sylvester

                   III.  Prognostic markers                                         Bassi, Chopin,
                                                                                                                        Cote

                   IV. Diagnostic markers                                          Fradet, Getzenberg,
                                                                                                                         Grossman

                    V. Epidemiology                                                               Malats, Schmitz-Dräger
 

13:00           Lunch

14:00           Presentation and report from the working groups speakers
14:00           I.   Technical innovations (models, arrays etc.)
14:30           II.   Statistical needs & GCP
15:00           III.  Prognostic markers
15:30           IV. Diagnostic markers
16:00           V.  Epidemiology
16:30           Summary and outline on the future of the IBCN

17:00           Joining the official Opening of the 16th Congress of the ESUR